{"New_Brunswick": {"PTC Therapeutics": "PTC Therapeutics is a US pharmaceutical company focused on the development of orally administered small molecule drugs that regulate gene expression by targeting post-translational control (PTC) mechanisms in orphan diseases.\nSince 2003, PTC has been working on a drug for Duchenne muscular dystrophy.\nIn September 2009, PTC has entered into an agreement with Roche for the development of orally bioavailable small molecules for central nervous system diseases."}}